These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12180448)

  • 1. Review: methadone dose reduction is better than alpha2 adrenergic agonists for treatment retention in opioid dependence.
    Yu E
    Evid Based Ment Health; 2002 Aug; 5(3):81. PubMed ID: 12180448
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha2-adrenergic agonists in opioid withdrawal.
    Gowing LR; Farrell M; Ali RL; White JM
    Addiction; 2002 Jan; 97(1):49-58. PubMed ID: 11895270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2001; (1):CD002024. PubMed ID: 11279747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid antagonists and adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2000; (2):CD002021. PubMed ID: 10796843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2003; (2):CD003409. PubMed ID: 12804464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews.
    Amato L; Davoli M; Ferri M; Gowing L; Perucci CA
    Drug Alcohol Depend; 2004 Mar; 73(3):219-26. PubMed ID: 15036544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological options for management of opioid dependence.
    Christie MJ; Harvey AI
    Drug Alcohol Rev; 1993; 12(1):71-80. PubMed ID: 16818314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
    Strain EC; Bigelow GE; Liebson IA; Stitzer ML
    JAMA; 1999 Mar; 281(11):1000-5. PubMed ID: 10086434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone maintenance at different dosages for opioid dependence.
    Faggiano F; Vigna-Taglianti F; Versino E; Lemma P
    Cochrane Database Syst Rev; 2003; (3):CD002208. PubMed ID: 12917925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response effects of methadone in the treatment of opioid dependence.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Ann Intern Med; 1993 Jul; 119(1):23-7. PubMed ID: 8498759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002207. PubMed ID: 12519569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
    Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
    Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid and α
    De Oliveira LB; Andrade CAF; De Luca LA; Colombari DSA; Menani JV
    Brain Res Bull; 2018 May; 139():174-181. PubMed ID: 29432796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.
    Stone LS; MacMillan LB; Kitto KF; Limbird LE; Wilcox GL
    J Neurosci; 1997 Sep; 17(18):7157-65. PubMed ID: 9278550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis.
    Meader N
    Drug Alcohol Depend; 2010 Apr; 108(1-2):110-4. PubMed ID: 20074867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction.
    Veilleux JC; Colvin PJ; Anderson J; York C; Heinz AJ
    Clin Psychol Rev; 2010 Mar; 30(2):155-66. PubMed ID: 19926374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid antagonists with minimal sedation for opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2002; (2):CD002021. PubMed ID: 12076431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.
    Farré M; Mas A; Torrens M; Moreno V; Camí J
    Drug Alcohol Depend; 2002 Feb; 65(3):283-90. PubMed ID: 11841899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial.
    San L; Camí J; Peri JM; Mata R; Porta M
    Br J Addict; 1990 Jan; 85(1):141-7. PubMed ID: 1968773
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.